MedPath

Controlling Myopia Progression With Soft Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Active Comparator
Device: Test Soft Contact Lens C
Device: Test Soft Contact Lens B
Registration Number
NCT01787760
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
221
Inclusion Criteria
  1. The subject must be between 8 and 12 years of age and of Asia origin.
  2. The subject's best sphere contact lens correction must lie between -0.75D (best of the two eyes) and -5.00D (worst of the two eyes)
  3. Astigmatism must be less than or equal to 1.00D
  4. Less than 1.00D difference in spherical equivalent between the two eyes
  5. The subject must have a best-corrected visual acuity of 20/25 and spherical equivalent refraction visual acuity of 20/25 or better in both eyes
  6. The subject must have at least 8D of accommodation.
  7. The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED CONSENT and the subject must read and sign the Child's Assent Form and be provided a copy of each form
  8. The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol
Exclusion Criteria
  1. Ocular or systemic allergies or diseases that may interfere with contact lens wear
  2. Systemic disease or autoimmune disease or use of medication (e.g. antihistamines), which may interfere with contact lens wear.
  3. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
  4. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormality of the cornea, which may contraindicate contact lens wear.
  5. Any ocular infection.
  6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  7. Any infectious disease (e.g. hepatitis, tuberculosis) or immunosuppressive disease (e.g. HIV).
  8. Diabetes.
  9. Anismetropia.
  10. Astigmatism of greater than 1.00D in either eye.
  11. Eye injury or eye surgery within eight weeks immediately prior to enrollment for this study.
  12. Previous refractive surgery, rigid contact lens wear, orthokeratology, keratoconus, or other corneal irregularity in either eye
  13. Strabismus in either eye
  14. Pupil or lid abnormality or infection in either eye
  15. Central corneal scar and aphakia in either eye
  16. Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear
  17. History of participation in clinical trials aimed to control myopia progression
  18. Surgically altered eyes, ocular infection of any type, ocular inflammation
  19. Subject has anterior chamber angle grade 2 or narrower

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Spectacle LensesActive ComparatorControl spectacle lenses worn daily.
Test Soft Contact Lens CTest Soft Contact Lens CLenses will be worn in a daily disposable modality
Test Soft Contact Lens BTest Soft Contact Lens BLenses will be worn in a daily disposable modality
Primary Outcome Measures
NameTimeMethod
Axial Length (Axial Elongation)Baseline and every 6 months post-baseline up to 3 years

Axial Length was measured with the IOLMaster at baseline, and then every 6 months throughout the course of the study. Five measurements were collected for each eye at each visit and the average of the 5 measurements were used for the analysis. Higher values of axial elongation indicate worse vision.

Spherical Equivalent RefractionBaseline and every 6 months post-baseline up to 3 years

Spherical Equivalent Refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values of spherical refraction indicate progression in Myopia.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Hong Kong Polytechnic University

🇭🇰

Hung Hom, Kowloon, Hong Kong

The Hong Kong Polytechnic University
🇭🇰Hung Hom, Kowloon, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath